Aggressive care at end of life for advanced lung cancer patients linked to poorer outcomes

May 25, 2017, University of Pennsylvania School of Nursing
Mary Ersek, Ph.D., RN, FPCN, holds a joint appointment at the Department of Veterans Affairs and Penn Nursing. Credit: Penn Nursing

For patients with advanced cancer, aggressive care—chemotherapy, mechanical ventilation, acute hospitalizations and intensive care unit admissions—at the end of life is commonplace. Yet until now, little is known about the relationship between patients' and families' satisfaction with this aggressive care within the last 30 days of life.

A new study, from the Department of Veterans Affairs and University of Pennsylvania School of Nursing (Penn Nursing), suggests that such care is not likely to contribute positively to patients' and families' experiences in the final days of . Furthermore, the study results support the view that aggressive care at the end of life for patients with is an indicator of poor-quality end-of-life care. The findings of the study are set for publication in an upcoming issue of the journal Cancer. A digital version of the study has been published online first and is accessible here. The study was conducted by an interdisciplinary group of investigators led by Mary Ersek, PhD, RN, FPCN, who holds a joint appointment at the Department of Veterans Affairs and Penn Nursing, and Vince Mor, PhD, from Brown University and the Providence VA Medical Center.

The researchers examined the care and outcomes for 847 Veterans with non-small cell lung cancer who died in a VA inpatient setting from 2010-2012. The study described rates of aggressive care and the association of aggressive care with bereaved families' evaluations of care in the final month of life. The investigators found that almost three-quarters of the sample had at least one episode of aggressive care in the last 30 days of life, which they defined as receipt of injectable chemotherapy or , or more than two hospitalizations or admission to an . These high rates of aggressive care were not associated with younger age. However, they may have reflected the VA's adoption of "concurrent care," which, unlike Medicare, allows patients to receive disease-modifying treatments along with hospice/palliative care.

The results also show that for Veterans dying in acute care or nursing home settings, aggresse care was associated with lower overall ratings of care than when patients did not have any aggressive care. However, for patients dying in VA inpatient hospice units, the difference in outcomes were not significant between patients receiving aggressive care and those who did not receive any aggressive care.

"It is important to give patients with advanced illness options for care, including concurrent care. However, we need to be mindful that aggressive care at the end of life is not associated with better patient outcomes, and guide patients accordingly," said Ersek. "Regardless of the treatment that choose, we need to be offering hospice and ."

Explore further: Patients who do not enroll in hospice are more likely to receive aggressive cancer care

Related Stories

Patients who do not enroll in hospice are more likely to receive aggressive cancer care

November 11, 2014
More patients with cancer use hospice today than ever before, but there are indications that care intensity outside of hospice is increasing, and length of hospice stay decreasing. Researchers at Brigham and Women's Hospital ...

Study examines spiritual support for patients with advanced cancer

May 6, 2013
A study by Tracy A. Balboni, M.D., M.P.H., of the Dana-Farber Cancer Institute, Boston, and colleagues suggests that spiritual care and end-of-life (EoL) discussions by the medical team may be associated with reduced aggressive ...

Advanced cancer patients receive aggressive care at high rates at the end of life

June 6, 2016
In the last month of their lives, younger cancer patients continued to be hospitalized and receive other aggressive treatment at high rates, a University of North Carolina Lineberger Comprehensive Cancer Center-led study ...

Palliative, hospice care lacking among dying cancer patients, Stanford researcher finds

May 27, 2016
Medical societies, including the American Society of Clinical Oncology, recommend that patients with advanced cancer receive palliative care soon after diagnosis and receive hospice care for at least the last three days of ...

Many Americans may get hospice care too late

November 3, 2014
(HealthDay)—Of the more than 1.5 million patients who received hospice care in the United States in 2013, one-third died within one week of getting it, a new report shows.

Dying patients who received palliative care visited the ER less

February 21, 2017
Community-based palliative care—care delivered at home, not the hospital—was associated with a 50 percent reduction in emergency department visits for patients in their last year of life. The results of an Australian ...

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.